Can metabolic stress and inflammation reduce active thyroid signaling?

Systemic physiological stressors, including metabolic stress, chronic inflammation, cortisol dysregulation, and nutrient deprivation, can profoundly suppress peripheral thyroid hormone activity without primary thyroid gland pathology, a state often characterized as non-thyroidal illness syndrome (NTIS).

Mechanistic pathways of thyroid suppression

• Deiodinase inhibition: Inflammatory cytokines (IL-6 and TNF-α) directly suppress hepatic type 1 (D1) and type 2 (D2) deiodinase activity and transcription while stimulating the inactivating type 3 deiodinase (D3). Disrupted cortisol rhythms (elevated or flat) further suppress the hypothalamic-pituitary-thyroid axis and peripheral T4-to-T3 conversion.
• Oxidative stress: Intracellular glutathione depletion functionally inhibits deiodinase catalysis. Conversely, restoring glutathione levels with N-acetylcysteine (NAC) has been shown to reverse cytokine-induced deiodinase inhibition.
• Impaired carrier transport: Caloric deprivation and poor protein status lower circulating carrier proteins, including thyroid-binding globulin (TBG), transthyretin, and albumin, which impairs cellular uptake of T4 into target tissues.

Impact on hepatic lipid clearance

• Lipid accumulation: Reduced intracellular T3 decreases nuclear thyroid hormone receptor beta (THRB) signaling. This downregulates low-density lipoprotein receptors (LDLR) and LDLR-related protein-1 (LRP1), and suppresses mitochondrial beta-oxidation. The clinical result is impaired clearance of apoB-containing lipoproteins and systemic dyslipidemia.

Bottom line

• Metabolic, inflammatory, and nutritional stressors converge to impair peripheral thyroid hormone transport and conversion, leading to localized tissue hypothyroidism and compromised hepatic lipid clearance via downregulated LDLR and LRP1 pathways.